Vivo Capital IX, LLC's Net Worth
$266 Million
Who is Vivo Capital IX, LLC?
Vivo Capital IX, LLC has an estimated net worth of $266 Million. This is based on reported shares across multiple companies, which include Instil Bio, Inc., Tarsus Pharmaceuticals, Inc., ALX ONCOLOGY HOLDINGS INC, IO Biotech, Inc., and Sierra Oncology, Inc..
SEC CIK
Vivo Capital IX, LLC's CIK is 0001750698
Past Insider Trading and Trends
2021 was Vivo Capital IX, LLC's most active year for acquiring shares with 5 total transactions. Vivo Capital IX, LLC's most active month to acquire stocks was the month of February. 2021 was Vivo Capital IX, LLC's most active year for disposing of shares, totalling 3 transactions. Vivo Capital IX, LLC's most active month to dispose stocks was the month of February. 2021 saw Vivo Capital IX, LLC paying a total of $15,100,000.00 for 15,502,332 shares, this is the most they've acquired in one year. In 2021 Vivo Capital IX, LLC cashed out on 10,343,824 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Instil Bio, Inc. (TIL) Snapshot price: $14.65
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 12.49M |
$20.00 |
—
| 12.49M |
Mar 23
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tarsus Pharmaceuticals, Inc. (TARS) Snapshot price: $30.59
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.22% | -5.37K |
$12.25 | -$65,831.50 | 2.47M |
May 5
| |||
Form 4
| -17.17% | -512.96K |
$13.39 | -$6,866,310.96 | 2.47M |
May 2 - May 4
| |||
Form 4
| -1.83% | -55.68K |
$29.79 | -$1,658,842.40 | 2.99M |
Jun 23 - Jun 25
| |||
Form 4
| -6.21% | -201.62K |
$29.05 | -$5,856,114.00 | 3.04M |
Jun 21 - Jun 22
| |||
Form 4
| -0.01% | -400.00 |
$30.37 | -$12,148.00 | 3.24M |
Apr 14
| |||
Form 4
|
∞
| 3.25M |
$16.00 |
—
| 3.25M |
Oct 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALX ONCOLOGY HOLDINGS INC (ALXO) Snapshot price: $1.91
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.22M |
$19.00 | $3,524,994.00 | 4.22M |
Jul 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IO Biotech, Inc. (IOBT) Snapshot price: $0.843
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.16M |
$1.90 | $5,999,998.60 | 3.16M |
Aug 9
| |||
Form 4
|
∞
| 3.02M |
$14.00 |
—
| 3.02M |
Nov 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sierra Oncology, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.33M |
$55.00 | -$183,123,160.00 |
0
|
Jul 1
| |||
Form 4
| +41.33% | 800K |
$27.00 | $21,600,000.00 | 2.74M |
Jan 31
| |||
Form 4
| +31.95% | 612.44K |
$13.20 | $8,084,168.40 | 2.53M |
Jan 26
| |||
Form 4
| +3,045.01% | 1.86M |
—
|
—
| 1.92M |
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||